Key result
Prolonged Impella unloading reduces cardiac inflammation and improves LVEF in fulminant myocarditis.
Why the study?
Haemodynamic load induces cardiac remodelling and inflammatory responses, prompting the hypothesis that myocarditis requires a strategy that provides circulatory support while unloading the left ventricle and mitigating inflammation.
Does prolonged mechanical unloading with Impella reduce myocardial inflammation and improve cardiac function in fulminant myocarditis?
Case Report (n=2)
Does prolonged mechanical unloading with Impella reduce myocardial inflammation and improve cardiac function in fulminant myocarditis?
Prolonged mechanical unloading via Impella may provide disease-modifying anti-inflammatory effects in fulminant myocarditis, promoting myocardial recovery.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Like with ECMO, the Impella device also provides circulatory support, but the heart is unloaded. The Impella, which is implanted in the left ventricle, acts like a propeller in a boat. It swaps the blood out, so the heart does not have to pump. This reduces the volume load, and therefore reduces the stress for the heart.”
May support anti-inflammatory effects of Impella unloading in fulminant myocarditis; single case leaves open whether this alters disease course.
AIMS: Haemodynamic load induces cardiac remodelling via mechano-transduction pathways, which can further trigger inflammatory responses. We hypothesized that particularly in an inflammatory disorder such as myocarditis, a therapeutic strategy is required which, in addition to providing adequate circulatory support, unloads the left ventricle, decreases cardiac wall stress, and mitigates inflammatory responses. METHODS AND RESULTS: Axial flow pumps such as the Impella systems comply with these requirements. Here, we report a potential mode-of-action of prolonged Impella support (PROPELLA concept) in fulminant myocarditis, including a decrease in cardiac immune cell presence, and integrin α1, α5, α6, α10 and β6 expression during unloading. CONCLUSION: PROPELLA may provide benefits beyond its primary function of mechanical circulatory support in the form of additional disease-altering effects, which may contribute to enhanced myocardial recovery/remission in patients with chronic fulminant myocarditis.
No takes yet. Share an insight, caveat, or question.
Spillmann et al. (2019) conducted a case report in Fulminant myocarditis (n=2). Prolonged Impella support (PROPELLA concept) was evaluated on Changes in endomyocardial inflammatory markers, immune cell infiltration, and left ventricular ejection fraction. Prolonged mechanical unloading with Impella in fulminant myocarditis decreased cardiac immune cell infiltration and inflammatory marker expression, improving left ventricular function.
Synapse has enriched 10 related papers. Consider them for comparative context: